Cancer patients who get COVID-19 are at high risk for poor outcomes, so they should be considered for priority access to COVID-19 vaccines, according to The American Association for Cancer Research's COVID-19 and Cancer Task Force. The task force reviewed the available data on fatality rates of patients with cancer who developed COVID-19 and based their recommendation on 28 publications; their position paper was published in the AACR journal Cancer Discovery. —Reuters Staff Source
